EUR/USD
1.19060
-0.055%
Gold
5035.06
-0.457%
Oil
64.179
-0.154%
USD/JPY
155.559
-0.209%
GBP/USD
1.36717
-0.175%
GBP/JPY
212.680
-0.371%
Real-time News
AstraZeneca: Drug prices in the U.S. will decrease, but drug prices in Europe must increase; we do not need new weight loss product deals.Ukrainian energy company DTEK said the Russian attack damaged its energy facilities in the Odessa region.On February 10th, Xinbao Co., Ltd. stated on its interactive platform that its coffee machine exports rank among the top in China; its own coffee machine brand, Barsetto, also performs well in domestic sales and has a certain degree of brand recognition in the coffee machine industry. However, the company currently focuses on export business, and the domestic sales of Barsetto account for a very small proportion of the companys total sales.February 10th - Sources say Indian regulators have banned two Indian exchanges from offering equity derivatives trading, requiring them to prioritize equity trading, according to two regulatory sources with direct knowledge of the matter. Information disclosed by the exchanges shows that late last year, the National Commodity and Derivatives Exchange of India (NCDEX) and the Metropolitan Stock Exchange (MSE) applied to the Securities and Exchange Board of India (SEBI) for approval to launch and develop spot and derivatives products for stocks. NCDEX primarily trades agricultural commodities, while MSE mainly offers currency derivatives, with very limited equity trading volume. Both exchanges have been seeking business diversification. SEBIs decision reflects its continued caution regarding Indias rapidly growing equity derivatives market – currently, the derivatives market is approximately twice the size of the spot market, while in major global markets, this proportion is only 2% to 3%.February 10th - Recent market rumors suggest that global agricultural technology giant Syngenta Group has officially begun preparations for a listing on the Hong Kong Stock Exchanges main board, with a fundraising target of up to US$10 billion, potentially becoming the largest IPO in Hong Kong in 2026. Syngenta declined to comment on the market rumors, stating, "We will continue to evaluate our capital markets strategy based on market conditions and other relevant factors in the best interests of our shareholders. The company has consistently indicated its intention to return to the capital markets when the time is right."
